BioMarin Pharmaceutical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2,222	1,312	942.84	755.13	724.53	587.28
Short-Term Investments	-	248.93	194.86	318.68	567.01	426.6
Cash & Short-Term Investments	2,222	1,561	1,138	1,074	1,292	1,014
Cash Growth	74.67%	37.17%	5.95%	-16.86%	27.39%	-4.83%
Accounts Receivable	903.91	908.21	660.54	633.7	461.32	373.4
Inventory	1,273	1,299	1,233	1,107	894.08	776.67
Other Current Assets	205.5	185.78	201.53	141.39	104.52	110.44
Total Current Assets	4,605	3,953	3,232	2,956	2,751	2,274
Net Property, Plant & Equipment	958.07	952.51	1,043	1,066	1,073	1,035
Other Intangible Assets	204.66	213.84	255.28	294.7	338.57	388.65
Goodwill	196.2	196.2	196.2	196.2	196.2	196.2
Long-Term Investments	-	492.24	521.24	611.14	333.84	507.79
Other Long-Term Assets	2,627	1,786	1,741	1,717	1,682	1,602
Total Assets	8,591	7,594	6,989	6,842	6,375	6,005
Accounts Payable	793.15	759.03	606.99	683.15	572.96	498.27
Short-Term Debt	-	-	-	493.88	-	-
Other Current Liabilities	-	-	-	-	15.93	48.23
Total Current Liabilities	793.15	759.03	606.99	1,177	588.88	546.5
Long-Term Debt	1,430	597.18	595.14	593.1	1,083	1,079
Other Long-Term Liabilities	155.48	150.82	128.82	119.94	100.02	113.53
Total Long-Term Liabilities	1,586	747.99	723.96	713.03	1,183	1,193
Total Liabilities	2,379	1,507	1,331	1,890	1,772	1,739
Common Stock	0.19	0.19	0.19	0.19	0.19	0.18
Treasury Stock	-10.45	-10.51	-11.23	-9.86	-8.86	-9.69
Additional Paid-in Capital	5,967	5,957	5,802	5,612	5,405	5,192
Accumulated Other Comprehensive Income	-4.24	-13.47	61.65	-28.79	-3.87	14.43
Retained Earnings	259.73	154.21	-194.7	-621.55	-789.2	-930.76
Shareholders' Equity	6,212	6,087	5,658	4,952	4,603	4,266
Total Liabilities & Equity	8,591	7,594	6,989	6,842	6,375	6,005
Total Debt	1,430	597.18	595.14	1,087	1,083	1,079
Net Cash (Debt)	792.15	963.43	542.57	-13.16	208.52	-65.2
Net Cash Growth	-17.78%	77.57%	-	-	-	-
Net Cash Per Share	4.07	4.88	2.76	-0.07	1.10	-0.36
Book Value	6,212	6,087	5,658	4,952	4,603	4,266
Book Value Per Share	31.90	30.84	28.76	25.84	24.36	23.33
Tangible Book Value	5,811	5,677	5,207	4,461	4,068	3,681
Tangible Book Value Per Share	29.84	28.76	26.47	23.28	21.53	20.13

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q